In diabetic myocardium, conditions like hyperglycemia, insulin resistance, and metabolic disturbances such as elevated serum glucose or lipids can induce FoxO1 expression, shifting its function from antioxidant to prooxidant. Here, FOXO1 is linked to Insulin resistance.